Mumbai-based Elder Pharmaceuticals has commenced commercial operations at its new U.S. FDA compliant manufacturing facility at Langa Road in Dehradun (Uttarakhand), which is an excise benefit zone.
The company plans to move manufacturing of all syrup-based products to this Rs.150-crore facility. These products are now either being manufactured or being outsourced.
Production lines
The facility has production lines for liquid orals, sterile injectables, cephalosporin block for tablets as well as dry powder injectables.
No comments:
Post a Comment